Get a Quote

TREPROSTINIL
CAS NO.: 81846-19-7
Chemical Formula: C23H34O5
Molecular Weight: 390.5000
DMF&GMP status: Please contact us for more details.
Description:
TREPROSTINIL API Supplier | CAS 81846-19-7 | Genegobio | Treprostinil dilates (widens) the arteries and decreases the amount of blood clotting platelets in your body. These effects lower blood pressure in the pulmonary artery that leads from the heart to the lungs.Treprostinil is used to treat pulmonary arterial hypertension (PAH). This medicine improves your ability to exercise.
Approvals
Active Ingredient Dosage Form; Route Strength Proprietary Name Applicant
TREPROSTINILINJECTABLE; IV (INFUSION) SUBCUTANEOUS10MG/MLREMODULINUNITED THERAP
TREPROSTINIL INJECTABLE; IV (INFUSION) SUBCUTANEOUS 1MG/ML REMODULIN UNITED THERAP
TREPROSTINIL INJECTABLE; IV (INFUSION) SUBCUTANEOUS 2.5MG/ML REMODULIN UNITED THERAP
TREPROSTINIL INJECTABLE; IV (INFUSION) SUBCUTANEOUS 5MG/ML REMODULIN UNITED THERAP
TREPROSTINIL SOLUTION; INHALATION 0.6MG/ML TYVASO UNITED THERAP
Patent Data
Patent No. Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code
676511724-Oct-17Y  
7999007 29-Mar-29   Y U - 1437
8497393 15-Dec-28 Y    
8653137 5-Sep-28     U - 1437
8658694 5-Sep-28     U - 1437
9199908 24-May-24     U - 1771
Exclusive Data
Exclusivity Code Exclusivity Expiration